COVID-19 “Rebound” associated with nirmatrelvir/ritonavir pre-hospital therapy
COVID-19 “Rebound” associated with nirmatrelvir/ritonavir pre-hospital therapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does COVID-19 “Rebound” associated with nirmatrelvir/ritonavir pre-hospital therapy have?
COVID-19 “Rebound” associated with nirmatrelvir/ritonavir pre-hospital therapy has 46 citations in the OpenAlex counts ScholarIQ stores.
When was COVID-19 “Rebound” associated with nirmatrelvir/ritonavir pre-hospital therapy published?
COVID-19 “Rebound” associated with nirmatrelvir/ritonavir pre-hospital therapy has 2022 year in the ScholarIQ index.
What is the open-access status of COVID-19 “Rebound” associated with nirmatrelvir/ritonavir pre-hospital therapy?
COVID-19 “Rebound” associated with nirmatrelvir/ritonavir pre-hospital therapy has bronze oa status in the ScholarIQ index.
What is the DOI of COVID-19 “Rebound” associated with nirmatrelvir/ritonavir pre-hospital therapy?
The DOI for COVID-19 “Rebound” associated with nirmatrelvir/ritonavir pre-hospital therapy is on the source record.
What is the PMID of COVID-19 “Rebound” associated with nirmatrelvir/ritonavir pre-hospital therapy?
The PMID for COVID-19 “Rebound” associated with nirmatrelvir/ritonavir pre-hospital therapy is on the source record.
What is the OpenAlex record for COVID-19 “Rebound” associated with nirmatrelvir/ritonavir pre-hospital therapy?
The OpenAlex for COVID-19 “Rebound” associated with nirmatrelvir/ritonavir pre-hospital therapy is on the source record.